Epilepsy
Conditions
Interventions
None listed
Sponsors
Tohoku University Graduate School of Medicine
Research Institute for Electronic Science, Hokkaido University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with epilepsy that do not fully respond to anti-epileptic drugs and need a vagus nerve stimulator implantation.
Exclusion criteria
Exclusion criteria: (1) Patients who cannot measure scheduled test items. (2) Patients who are unable to visit the outpatient clinic for follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in C-peptide levels before and 1 year after implantation of vagus nerve stimulator | — |
Secondary
| Measure | Time frame |
|---|---|
| Increase in C-peptide levels at 6 months and 2 years after vagus nerve stimulation, changes in glucose tolerance test, glucagon test, urinary C-peptide, continuous glucose, ECG R-R interval coefficient of variation, InBody, and blood samples at each evaluation time point. | — |
Countries
Japan
Contacts
Public ContactSHINICHIRO OSAWA
Tohoku University Graduate School of Medicine Department of Neurosurgery
Outcome results
None listed